FDA Sees More Breakthrough Drugs, Woodcock Says

FDA Sees More Breakthrough Drugs, Woodcock Says Play

Feb. 11 (Bloomberg) -- Janet Woodcock, director of the Food and Drug Administration's Center for Drug Evaluation and Research, talks about the FDA's efforts to speed drugs to market and policies on generic and bio-similar treatments. Woodcock, speaking at Bloomberg's "State of Health Care 2013" summit in New York, also comments on drug shortages. (Source: Bloomberg)

Feed Most Popular

  • On Air Now

    2015 Surveillance Watch Now

  • Next

    PAID PROGRAMMING

blog comments powered by Disqus